Showing 17,621 - 17,640 results of 44,078 for search '(( 50 ((n decrease) OR (a decrease)) ) OR ( 5 ((teer decrease) OR (mean decrease)) ))', query time: 1.26s Refine Results
  1. 17621

    S2 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  2. 17622

    Study protocol. by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  3. 17623

    S1 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  4. 17624
  5. 17625
  6. 17626
  7. 17627

    Chronic treatment with carvacrol improves passive avoidance memory in a rat model of Parkinson's disease by Hossein Haddadi (4895290)

    Published 2018
    “…The 6-OHDA-lesioned rats showed contralateral rotations towards the lesion side, which was accompanied by learning and memory deficits in a passive avoidance test and a decrease in tail withdrawal latency in a tail flick test at the end of week 6. …”
  8. 17628

    Vibration–induced enhancement of stick balancing skill as a function of vibration-induced amplitude lowering. by John G. Milton (223908)

    Published 2013
    “…Data is obtained from three subjects using three different vibration frequencies (15 Hz, 25 Hz, 50 Hz) on three different days. Relative survival is the same as defined in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007427#pone-0007427-g003" target="_blank">Figure 3</a>. …”
  9. 17629

    Image3_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”
  10. 17630

    Image1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpg by Heather A. Ogana (11774297)

    Published 2023
    “…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”
  11. 17631

    HBV Infection in Relation to Consistent Condom Use: A Population-Based Study in Peru by Antonio Bernabe-Ortiz (90790)

    Published 2011
    “…Consistent condom use was associated with decreased risk of anti-HBc. Findings from this study emphasize the need of primary prevention programs (vaccination) especially in the jungle population, and imply that condom use promotion might be a potential strategy to prevent HBV infection.…”
  12. 17632

    Granulocyte Colony-Stimulating Factor Reduces Fibrosis in a Mouse Model of Chronic Pancreatitis by Wey-Ran Lin (615284)

    Published 2014
    “…We aimed to test the effect of G-CSF on fibrosis in a mouse model of CP.</p><p>Methods</p><p>CP was induced in C57Bl/6J mice by consecutive cerulein injection (50 µg/kg/day, 2 days a week) for 6 weeks. …”
  13. 17633

    Image2_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”
  14. 17634
  15. 17635
  16. 17636

    Optical coherence tomography findings. by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  17. 17637

    S1 Data - by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  18. 17638

    Clinical demographics and angiographic findings. by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  19. 17639

    Physiological parameters. by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  20. 17640